Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2023-07-21

First RSV vaccine to protect infants up to 6 months of age and older adults

View source ↗

Summary

EMA announces the first RSV vaccine that can protect infants up to 6 months of age and older adults, marking a pivotal approval for RSV prevention across these …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSV vaccine (respiratory syncytial virus vaccine)